Role proposition
This is a full-Board strategy and capital seat rather than a committee title in search of content. The company needs an independent director who can examine how capital is distributed across businesses, products and channels; whether returns compensate for risk and operating complexity; and which strategic options preserve resilience under a less favourable funding or credit environment.
The portfolio lens
Management will be expected to present each material business as a claim on capital, liquidity, technology, leadership capacity and reputation. The appointee will test whether reported return reflects the full cost of credit, funding, operations, acquisition, compliance and capital. Growth businesses should show cohort maturation and cash conversion; mature businesses should show why retained capital remains superior to redeployment.
The director will resist average economics where distribution, customer, product or geography produces different risk. Portfolio decisions should address concentration, correlated downside and the ease with which an exposure can actually be reduced—not only stated limits.
Strategic choices
Organic expansion, acquisition, partnership and divestment will be compared using a common decision frame: strategic advantage, control, execution capacity, capital consumed, downside, reversibility and measurable milestones. For acquisitions, the Board should see integration cost, data and technology debt, customer or funding concentration, talent retention and regulatory dependencies before valuation enthusiasm takes over.
Digital and analytics investment should be reviewed for realised decision or operating benefit, not installation. Where models influence credit, pricing, collections or customer treatment, oversight must include data lineage, validation, overrides, drift and remedy.
Risk and funding dialogue
The appointee will participate in annual appetite and stress discussions, asking whether the assumed management actions remain available when market liquidity, asset quality and reputation deteriorate together. Contingent funding, securitisation, asset sale and capital actions need credible execution timing, counterparties and governance. The Board should know what it will stop doing before minimum constraints force the decision.
Measures of contribution
After twelve months, capital allocation papers should show comparable risk-adjusted economics, post-investment reviews should reveal whether approved benefits were realised, and the Board should have explicit triggers for slowing, exiting or recapitalising a business. Strategy minutes should capture rejected alternatives and the assumptions that would reopen them.
The director will guard against false precision. Not every business can be reduced to one return number, particularly where optionality, regulatory permission or distribution capability matters. Where comparison requires judgement, the paper should state the judgement and show what would make it wrong. The goal is not a mechanistic ranking; it is a decision record that allows the Board to learn when outcomes diverge from the case it approved.
Who should apply
Candidates may have led a bank, NBFC, investment, insurance or diversified financial institution; served as CFO, CRO or business president; or governed capital as a regulator or long-horizon investor. Direct accountability for balance sheet, portfolio restructuring, acquisition or funding is important. The candidate must be independently minded, free of material conflicts and compliant with the Independent Directors' Databank framework. The expected commitment includes Board cycles, annual strategy and risk sessions, and focused reviews of major capital proposals.
Registration on the IICA Independent Directors Databank is required before appointment. A DIN is not needed to apply: where an appointee does not yet hold one, it is obtained through the appointing company at the point of appointment.